Abstract

Coronavirus infection has had a significant impact on people around the world, however, there is a category of patients who are at high risk of severe disease - kidney transplant recipients. The high risk is due to the presence of a pronounced comorbid background, long-term background immunosuppression, a high risk of secondary infection, and graft dysfunction as a result of a severe infection. This paper presents a series of clinical cases of severe COVID-19 infection in kidney transplant recipients. We have demonstrated that timely diagnosis and intensive therapy, including both adequate drug therapy and the use of renal replacement therapy in the form of hemodialysis and extracorporeal detoxification methods, can not only save the lives of such patients, but also preserve a functioning kidney transplant.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call